Diagnostic imaging interpretation involves distilling multimodal clinical information into text form, a task well-suited to augmentation by generative artificial intelligence (AI). However, to our knowledge, impacts of AI-based draft radiological reporting remain unstudied in clinical settings. To prospectively evaluate the association of radiologist use of a workflow-integrated generative model capable of providing draft radiological reports for plain radiographs across a tertiary health care system with documentation efficiency, the clinical accuracy and textual quality of final radiologist reports, and the model's potential for detecting unexpected, clinically significant pneumothorax. This prospective cohort study was conducted from November 15, 2023, to April 24, 2024, at a tertiary care academic health system. The association between use of the generative model and radiologist documentation efficiency was evaluated for radiographs documented with model assistance compared with a baseline set of radiographs without model use, matched by study type (chest or nonchest). Peer review was performed on model-assisted interpretations. Flagging of pneumothorax requiring intervention was performed on radiographs prospectively. The primary outcomes were association of use of the generative model with radiologist documentation efficiency, assessed by difference in documentation time with and without model use using a linear mixed-effects model; for peer review of model-assisted reports, the difference in Likert-scale ratings using a cumulative-link mixed model; and for flagging pneumothorax requiring intervention, sensitivity and specificity. A total of 23 960 radiographs (11 980 each with and without model use) were used to analyze documentation efficiency. Interpretations with model assistance (mean [SE], 159.8 [27.0] seconds) were faster than the baseline set of those without (mean [SE], 189.2 [36.2] seconds) (P = .02), representing a 15.5% documentation efficiency increase. Peer review of 800 studies showed no difference in clinical accuracy (χ2 = 0.68; P = .41) or textual quality (χ2 = 3.62; P = .06) between model-assisted interpretations and nonmodel interpretations. Moreover, the model flagged studies containing a clinically significant, unexpected pneumothorax with a sensitivity of 72.7% and specificity of 99.9% among 97 651 studies screened. In this prospective cohort study of clinical use of a generative model for draft radiological reporting, model use was associated with improved radiologist documentation efficiency while maintaining clinical quality and demonstrated potential to detect studies containing a pneumothorax requiring immediate intervention. This study suggests the potential for radiologist and generative AI collaboration to improve clinical care delivery.

Placental volume measurements can potentially identify high-risk pregnancies. We aimed to develop and validate a new method for placental volume measurements using tracked 2D ultrasound and automatic image segmentation. We included 43 pregnancies at gestational week 27 and acquired placental images using a 2D ultrasound probe with position tracking, and trained a convolutional neural network (CNN) for automatic image segmentation. The automatically segmented 2D images were combined with tracking data to calculate placental volume. For 15 of the included pregnancies, placental volume was also estimated based on MRI examinations, 3D ultrasound and manually segmented 2D ultrasound images. The ultrasound methods were compared to MRI (gold standard). The CNN demonstrated good performance in automatic image segmentation (F1-score 0.84). The correlation with MRI-based placental volume was similar for tracked 2D ultrasound using automatically segmented images (absolute agreement intraclass correlation coefficient [ICC] 0.58, 95% CI 0.13-0.84) and manually segmented images (ICC 0.59, 95% CI 0.13-0.84). The 3D ultrasound method showed lower ICC (0.35, 95% CI -0.11 to 0.74) than the methods based on tracked 2D ultrasound. Tracked 2D ultrasound with automatic image segmentation is a promising new method for placental volume measurements and has potential for further improvement.

To evaluate a Compressed Sense Artificial Intelligence framework (CSAI) incorporating parallel imaging, compressed sense (CS), and deep learning for high-resolution MRI of the hip, comparing it with standard-resolution CS imaging. Thirty-two patients with femoroacetabular impingement syndrome underwent 3 T MRI scans. Coronal and sagittal intermediate-weighted TSE sequences with fat saturation were acquired using CS (0.6 ×0.8 mm resolution) and CSAI (0.3 ×0.4 mm resolution) protocols in comparable acquisition times (7:49 vs. 8:07 minutes for both planes). Two readers systematically assessed the depiction of the acetabular and femoral cartilage (in five cartilage zones), labrum, ligamentum capitis femoris, and bone using a five-point Likert scale. Diagnostic confidence and abnormality detection were recorded and analyzed using the Wilcoxon signed-rank test. CSAI significantly improved the cartilage depiction across most cartilage zones compared to CS. Overall Likert scores were 4.0 ± 0.2 (CS) vs 4.2 ± 0.6 (CSAI) for reader 1 and 4.0 ± 0.2 (CS) vs 4.3 ± 0.6 (CSAI) for reader 2 (p ≤ 0.001). Diagnostic confidence increased from 3.5 ± 0.7 and 3.9 ± 0.6 (CS) to 4.0 ± 0.6 and 4.1 ± 0.7 (CSAI) for readers 1 and 2, respectively (p ≤ 0.001). More cartilage lesions were detected with CSAI, with significant improvements in diagnostic confidence in certain cartilage zones such as femoral zone C and D for both readers. Labrum and ligamentum capitis femoris depiction remained similar, while bone depiction was rated lower. No abnormalities detected in CS were missed in CSAI. CSAI provides high-resolution hip MR images with enhanced cartilage depiction without extending acquisition times, potentially enabling more precise hip cartilage assessment.

Osteoporosis, a prevalent skeletal disorder, necessitates accurate and accessible diagnostic tools for effective disease management and fracture prevention. While dual-energy X-ray absorptiometry (DXA) remains the clinical standard for bone mineral density (BMD) assessment, its limitations, including ionizing radiation exposure and susceptibility to artifacts, underscore the need for alternative technologies. Ultrasound-based methods have emerged as promising radiation-free alternatives, with radiofrequency echographic multi-spectrometry (REMS) representing a significant advancement in axial skeleton assessment, specifically at the lumbar spine and proximal femur. REMS analyzes unfiltered radiofrequency ultrasound signals, providing not only BMD estimates but also a novel fragility score (FS), which reflects bone quality and microarchitectural integrity. This review critically evaluates the underlying principles, diagnostic performance, and clinical applications of REMS. It compares REMS with DXA, quantitative computed tomography (QCT), and trabecular bone score (TBS), highlighting REMS's potential advantages in artifact-prone scenarios and specific populations, including children and patients with secondary osteoporosis. The clinical utility of REMS in fracture risk prediction and therapy monitoring is explored alongside its operational precision, cost-effectiveness, and portability. In addition, the integration of artificial intelligence (AI) within REMS software has enhanced its capacity for artifact exclusion and automated spectral interpretation, improving usability and reproducibility. Current limitations, such as the need for broader validation and guideline inclusion, are identified, and future research directions are proposed. These include multicenter validation studies, development of pediatric and secondary osteoporosis reference models, and deeper evaluation of AI-driven enhancements. REMS offers a compelling, non-ionizing alternative for axial bone health assessment and may significantly advance the diagnostic landscape for osteoporosis care.

The objective of this study was to evaluate a combination of deep learning (DL)-reconstructed parallel acquisition technique (PAT) and simultaneous multislice (SMS) acceleration imaging in comparison to conventional knee imaging. Adults undergoing knee magnetic resonance imaging (MRI) with DL-enhanced acquisitions were prospectively analyzed from December 2023 to April 2024. The participants received T1 without fat saturation and fat-suppressed PD-weighted TSE pulse sequences using conventional two-fold PAT (P2) and either DL-enhanced four-fold PAT (P4) or a combination of DL-enhanced four-fold PAT with two-fold SMS acceleration (P4S2). Three independent readers assessed image quality, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and radiomics features. 34 participants (mean age 45±17years; 14 women) were included who underwent P4S2, P4, and P2 imaging. Both P4S2 and P4 demonstrated higher CNR and SNR values compared to P2 (P<.001). P4 was diagnostically inferior to P2 only in the visualization of cartilage damage (P<.005), while P4S2 consistently outperformed P2 in anatomical delineation across all evaluated structures and raters (P<.05). Radiomics analysis revealed significant differences in contrast and gray-level characteristics among P2, P4, and P4S2 (P<.05). P4 reduced time by 31% and P4S2 by 41% compared to P2 (P<.05). P4S2 DL acceleration offers significant advancements over P4 and P2 in knee MRI, combining superior image quality and improved anatomical delineation at significant time reduction. Its improvements in anatomical delineation, energy consumption, and workforce optimization make P4S2 a significant step forward.

Effective intervention for mild cognitive impairment (MCI) is key for preventing dementia. As a neuroprotective agent, butylphthalide has the potential to treat MCI due to Alzheimer disease (AD). However, the pharmacological mechanism of butylphthalide from the brain network perspective is not clear. Therefore, we aimed to investigate the multimodal brain network changes associated with butylphthalide treatment in MCI due to AD. A total of 270 patients with MCI due to AD received either butylphthalide or placebo at a ratio of 1:1 for 1 year. Effective treatment was defined as a decrease in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog) > 2.5. Brain networks were constructed using T1-magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. A support vector machine was applied to develop predictive models. Both treatment (drug vs. placebo)-time interactions and efficacy (effective vs. ineffective)-time interactions were detected on some overlapping structural network metrics. Simple effects analyses revealed a significantly increased global efficiency in the structural network under both treatment and effective treatment of butylphthalide. Among the overlapping metrics, an increased degree centrality of left paracentral lobule was significantly related to poorer cognitive improvement. The predictive model based on baseline multimodal network metrics exhibited high accuracy (88.93%) of predicting butylphthalide's efficacy. Butylphthalide may restore abnormal organization in structural networks of patients with MCI due to AD, and baseline network metrics could be predictive markers for therapeutic efficacy of butylphthalide. This study was registered in the Chinese Clinical Trial Registry (Registration Number: ChiCTR1800018362, Registration Date: 2018-09-13).

PurposeWe aimed to investigate the external validation and performance of an FDA-approved deep learning model in labeling intracranial hemorrhage (ICH) cases on a real-world heterogeneous clinical dataset. Furthermore, we delved deeper into evaluating how patients' risk factors influenced the model's performance and gathered feedback on satisfaction from radiologists of varying ranks.MethodsThis prospective IRB approved study included 5600 non-contrast CT scans of the head in various clinical settings, that is, emergency, inpatient, and outpatient units. The patients' risk factors were collected and tested for impacting the performance of DL model utilizing univariate and multivariate regression analyses. The performance of DL model was contrasted to the radiologists' interpretation to determine the presence or absence of ICH with subsequent classification into subcategories of ICH. Key metrics, including accuracy, sensitivity, specificity, positive predictive value, and negative predictive value, were calculated. Receiver operating characteristics curve, along with the area under the curve, were determined. Additionally, a questionnaire was conducted with radiologists of varying ranks to assess their experience with the model.ResultsThe model exhibited outstanding performance, achieving a high sensitivity of 89% and specificity of 96%. Additional performance metrics, including positive predictive value (82%), negative predictive value (97%), and overall accuracy (94%), underscore its robust capabilities. The area under the ROC curve further demonstrated the model's efficacy, reaching 0.954. Multivariate logistic regression revealed statistical significance for age, sex, history of trauma, operative intervention, HTN, and smoking.ConclusionOur study highlights the satisfactory performance of the DL model on a diverse real-world dataset, garnering positive feedback from radiology trainees.

Accurate internal target volume (ITV) estimation is essential for effective and safe radiation therapy in liver cancer. This study evaluates the clinical value of an ultraquality 4-dimensional magnetic resonance imaging (UQ 4D-MRI) technique for ITV estimation. The UQ 4D-MRI technique maps motion information from a low spatial resolution dynamic volumetric MRI onto a high-resolution 3-dimensional MRI used for radiation treatment planning. It was validated using a motion phantom and data from 13 patients with liver cancer. ITV generated from UQ 4D-MRI (ITV_4D) was compared with those obtained through isotropic expansions (ITV_{2 mm} and ITV_{5 mm}) and those measured using conventional 4D-computed tomography (computed tomography-based ITV, ITV_CT) for each patient. Phantom studies showed a displacement measurement difference of <5% between UQ 4D-MRI and single-slice 2-dimensional cine MRI. In patient studies, the maximum superior-inferior displacements of the tumor on UQ 4D-MRI showed no significant difference compared with single-slice 2-dimensional cine imaging (<i>P</i> = .985). Computed tomography-based ITV showed no significant difference (<i>P</i> = .72) with ITV_4D, whereas ITV_{2 mm} and ITV_{5 mm} significantly overestimated the volume by 29.0% (<i>P</i> = .002) and 120.7% (<i>P</i> < .001) compared with ITV_4D, respectively. UQ 4D-MRI enables accurate motion assessment for liver tumors, facilitating precise ITV delineation for radiation treatment planning. Despite uncertainties from artificial intelligence-based delineation and variations in patients' respiratory patterns, UQ 4D-MRI excels at capturing tumor motion trajectories, potentially improving treatment planning accuracy and reducing margins in liver cancer radiation therapy.

Overuse of radiography studies and underuse of conservative therapies for cranial deformities in neonates is a known inefficiency in pediatric craniofacial healthcare. This study sought to establish whether the introduction of artificial intelligence (AI)-generated craniometrics and craniometric interpretations into craniofacial clinical workflow improved resource utilization patterns in the initial evaluation and management of neonatal cranial deformities. A retrospective chart review of pediatric patients referred for head shape concerns between January 2019 and June 2023 was conducted. Patient demographics, final encounter diagnosis, review of an AI analysis, and provider orders were documented. Patients were divided based on whether an AI cranial deformity analysis was documented as reviewed during the index evaluation, then both groups were propensity matched. Rates of index-encounter radiology studies, physical therapy (PT), orthotic therapy, and craniofacial specialist follow-up evaluations were compared using logistic regression and ANOVA analyses. One thousand patient charts were reviewed (663 conventional encounters, 337 AI-assisted encounters). One-to-one propensity matching was performed between these groups. AI models were significantly more likely to be reviewed during telemedicine encounters and advanced practice provider (APP) visits (54.8% telemedicine vs 11.4% in-person, p < 0.0001; 12.3% physician vs 44.4% APP, p < 0.0001). All AI diagnoses of craniosynostosis versus benign deformities were congruent with final diagnoses. AI model review was associated with a significant increase in the use of orthotic therapies for neonatal cranial deformities (31.5% vs 38.6%, p = 0.0132) but not PT or specialist follow-up evaluations. Radiology ordering rates did not correlate with AI-interpreted data review. As neurosurgeons and pediatricians continue to work to limit neonatal radiation exposure and contain healthcare costs, AI-assisted clinical care could be a cheap and easily scalable diagnostic adjunct for reducing reliance on radiography and encouraging adherence to established clinical guidelines. In practice, however, providers appear to default to preexisting diagnostic biases and underweight AI-generated data and interpretations, ultimately negating any potential advantages offered by AI. AI engineers and specialty leadership should prioritize provider education and user interface optimization to improve future adoption of validated AI diagnostic tools.

To assess the performance of an industry-developed deep learning (DL) algorithm to reconstruct low-resolution Cartesian T1-weighted dynamic contrast-enhanced (T1w) and T2-weighted turbo-spin-echo (T2w) sequences and compare them to standard sequences. Female patients with indications for breast MRI were included in this prospective study. The study protocol at 1.5 Tesla MRI included T1w and T2w. Both sequences were acquired in standard resolution (T1_S and T2_S) and in low-resolution with following DL reconstructions (T1_DL and T2_DL). For DL reconstruction, two convolutional networks were used: (1) Adaptive-CS-Net for denoising with compressed sensing, and (2) Precise-Image-Net for resolution upscaling of previously downscaled images. Overall image quality was assessed using 5-point-Likert scale (from 1=non-diagnostic to 5=excellent). Apparent signal-to-noise (aSNR) and contrast-to-noise (aCNR) ratios were calculated. Breast Imaging Reporting and Data System (BI-RADS) agreement between different sequence types was assessed. A total of 47 patients were included (mean age, 58±11 years). Acquisition time for T1_DL and T2_DL were reduced by 51% (44 vs. 90 s per dynamic phase) and 46% (102 vs. 192 s), respectively. T1_DL and T2_DL showed higher overall image quality (e.g., 4 [IQR, 4-4] for T1_S vs. 5 [IQR, 5-5] for T1_DL, P<0.001). Both, T1_DL and T2_DL revealed higher aSNR and aCNR than T1_S and T2_S (e.g., aSNR: 32.35±10.23 for T2_S vs. 27.88±6.86 for T2_DL, P=0.014). Cohen k agreement by BI-RADS assessment was excellent (0.962, P<0.001). DL for denoising and resolution upscaling reduces acquisition time and improves image quality for T1w and T2w breast MRI.